Sept 17 (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and those at high risk of illness, after rejecting a call for broader approval. (Reporting By Peter Henderson Editing by Bill Berkrot)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.1 USD | -0.87% | +9.75% | +21.74% |
05-07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
05-06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+47.07% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B | |
+21.07% | 11.81B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : U.S. FDA vaccine advisers vote in favor of COVID-19 booster shot for those 65 and older